News
Last May Bioiberica had a non scheduled inspection from the US FDA in its facility in Geneva (Nebraska) where the first steps of heparin sodium production are performed.
The US Authorities inspected the facilities related to the production of heparin in the plants of Palafolls and Probisa.
They focused on ensuring that our traceability system meets the standards currently required by the FDA, which apply to the documentary as well as to the production levels (from the slaughterhouses, to the control of our satellite plants until the final API).
in order to promote the development of new markets of sodium heparin, lithium heparin and heparin derivates.
Rheumatologists from across the country attended this morning the presentation of a new diagnosis tool that can detect worst-prognosis patients, those that are at greatest risk of needing short-term prosthetic surgery
A simple saliva analysis identifies genetic changes associated with rapid disease progressionPhysicians can identify patients having the worst prognosis, those that are at greatest risk of needing short-term prosthetic surgeryThis information allows physicians to design personalized treatments and influence the diseases progression; reducing the need for prosthetic surgery and improving the pa